GoldBamboo.com - Knowledge is strong medicine
  

Incidence and Severity of Cardiorespiratory Events in Infants at Increased Epidemiological Risk for Sudden Infant Death Syndrome (SIDS) - Article


  Not Signed In - Sign In / Register






Vaccines and Sudden Infant Death Syndrome


Clinical Trial: Incidence and Severity of Cardiorespiratory Events in Infants at Increased Epidemiological Risk for Sudden Infant Death Syndrome (SIDS)

This study has been completed.

Sponsors and Collaborators: National Institute of Child Health and Human Development (NICHD)
Yale University
Information provided by: Office of Rare Diseases (ORD)

Purpose

OBJECTIVES: I. Assess and compare the incidence and severity of cardiorespiratory events documented by home monitoring in infants at increased epidemiological risk for sudden infant death syndrome (SIDS). II. Determine the antecedent medical, demographic, physiologic, and behavioral characteristics that predict the incidence of cardiorespiratory events documented by home monitoring.

Condition
Sudden Infant Death Syndrome
Apnea

MedlinePlus related topics:  Respiratory Diseases;   Sudden Infant Death Syndrome

Study Type: Observational
Study Design: Screening

Further Study Details: 

Expected Total Enrollment:  900

Study start: May 1994;  Study completion: August 1999

PROTOCOL OUTLINE: This is a multicenter collaborative study. Patients are stratified into 4 groups: healthy term infants, apnea of infancy, subsequent siblings of SIDS victims, and preterm infants. The caregivers are trained in the use of home monitor equipment and in the graded response to monitor alarms (observation, gentle stimulation, more vigorous stimulation, mouth to mouth breathing, and full cardiopulmonary resuscitation). Caregivers undergo infant cardiopulmonary resuscitation (CPR) training (not required for caregivers of healthy term infants). Demographic information is obtained on each infant. A 30 second recording of each infant's cry is performed at study entry and at 1 month corrected age, and at the polysomnogram. A urine sample is collected and frozen. The CHIME monitor is used during sleep and whenever the infant is not being observed. An overnight polysomnography is performed within 2 weeks of study entry. At 1, 2.5, 6, and 12 months corrected age, infants participate in a clinical evaluation. Neurodevelopmental status is assessed at 1, 4, and 12 months corrected age.

Eligibility

Ages Eligible for Study:  up to  1 Year,  Genders Eligible for Study:  Both

Accepts Healthy Volunteers

Criteria

PROTOCOL ENTRY CRITERIA: --Disease Characteristics-- Healthy term infants or infants at high epidemiologic risk for SIDS meeting one of the following criteria: Apnea of infancy Siblings of SIDS victim Preterm infants --Prior/Concurrent Therapy-- All study groups: No home treatment with supplemental oxygen, bronchodilators, diuretics, steroids, or respiratory stimulants other than methylxanthines Healthy term infants: No prior/concurrent medications or treatments except: Vitamins Eye prophylaxis Vaccines --Patient Characteristics-- All study groups: No concurrent pneumonia No history of congenital heart disease Current asymptomatic PDA or ASD, or small muscular VSD, not requiring treatment are allowed No ventriculoperitoneal shunt No home anticonvulsant therapy No congenital brain anomalies documented by head ultrasound, CT, or MRI No gastroesophageal reflux being treated by medication No midfacial hypoplasia or cleft palate No prior inborn error of metabolism (including MCAD or carnitine deficiency) No caregiver currently using illicit drugs No language barrier between researcher and caregiver Must have telephone in the home Healthy term infants: Gestational age at birth of 38-42 weeks Age no greater than 30 days postnatally for planned monitor start date Not admitted to a special care nursery Nursery discharge on/before date of maternal discharge or 48 hours of age, whichever is later No history of apnea or apparent life threatening event (ALTE) No history of SIDS in full or half siblings No history of SIDS in cousins, aunts, and uncles in the last 10 years 1 minute APGAR at least 4 5 minute APGAR at least 7 Apnea of infancy: Diagnosed ALTE (during sleep or awake) characterized by color change, muscle tone change, and apnea requiring intervention No specific etiology for the ALTE after a thorough diagnostic evaluation At least 12 hours of age and less than 6 months postnatal age when ALTE occurred Greater than 34 weeks gestation Weight greater than 1750 g Siblings of SIDS victim Half or full sibling of at least one previous SIDS victim Less than 1 month postnatal age at study entry Autopsy report confirmed SIDS in sibling Preterm infants Birth weight less than 1750 g Gestational age no greater than 34 weeks Postnatal age less than 120 days at time of hospital discharge

Location Information

Study chairs or principal investigators

George Lister,  Study Chair,  Yale University   

More Information

Publications

Corwin M, Colton T, Neuman M, et al.: The CHIME pilot study. The American Pediatric Society and the Society for Pediatric Research annual meeting. San Diego, CA. Pediatric Research 37(4 Pt.2): 389A, 1995.

Silvestri JM, Hufford D, Durham J, et al.: Assessment of compliance with home cardio-respiratory monitoring in infants at risk for sudden infant death syndrome (SIDS).The American Pediatric Society and the Society for Pediatric Research annual meeting. San Diego, CA. Pediatric Research 37(4 pt 2): 144A, 1995.

Silvestri JM, Corwin MJ, Tinsley L, et al.: Assessment of sleep position among infants at risk of sudden infant death syndrome (SIDS). The American Pediatric Society and the Society for Pediatric Research annual meeting. Washington, DC. Pediatric Research 39(4 pt 2): 113A, 1996.

Silvestri JM, Crowell DH, Peucker M, et al.: Successful use of a home respiratory inductance plethysmography (RIP) monitor in infants at risk for sudden infant death syndrome (SIDS). The American Pediatric Society and the Society for Pediatric Research. Washington, DC. Pediatric Research 39(4 pt 2): 141A, 1996.

Hoppenbrouwers T, Neuman M, Corwin M, et al.: Multivariate cardio-respiratory monitoring at home: Collaborative Home Infant Monitoring Evaluation (CHIME). Proceedings of the 18th Annual International Conference of the IEEE Engineering in Medicine and Biology Society November 1996.

Silvestri JM, Mulvey KP, Corwin MJ, et al.: Assessment of sleep position over time among infants at risk of sudden infant death syndrome (SIDS) and healthy term infants. The American Pediatric Society and the Society for Pediatric Research annual meeting. Washington, DC. Pediatric Research 41(4 pt 2): 79A, 1997.

Hunt CE, Corwin MJ, Peucker M, et al.: Longitudinal assessment of oxygen saturation and sleep position in healthy term infants during the first 6 months of life. The American Pediatric Society and the Society for Pediatric Research annual meeting. Washington, DC. Pediatric Research 41(4 pt 2): 199A, 1997.

Corwin MJ, Lister G, Silvestri J, et al.: Inter-rater agreement in scoring home cardio-respiratory tracings. The American Pediatric Society and the Society for Pediatric Research annual meeting. Washington DC. Pediatric Research 41(4 pt 2): 301A, 1997.

Corwin MJ, Weese-Mayer DE, Neuman MR, et al.: Apnea duration: respiratory inductance plethysmography (RIP) and transthoracic impedance(TTI) pneumography vs. polysomnography (PSG). The American Pediatric Society and the Society for Pediatric Research annual meeting. Washington, DC. Pediatric Research 41(4 pt.2): 301A, 1997.

Silvestri JM, Smok-Pearsall SM, Bak SM, et al.: Assessment of risk factors among infants at increased risk of sudden infant death syndrome(SIDS). The American Pediatric Society and the Society for Pediatric Research annual meeting. Washington, DC. Pediatric Research 41(4 pt 2): 98A, 1997.

Ramanathan R Corwin MJ, Hunt CE, et al.: Preterm infants have prolonged apneas with obstruction and associated O2 desaturation at home. The American Pediatric Society and the Society for Pediatric Research annual meeting. Washington, DC. Pediatric Research 41(4 pt 2): 171A, 1997.

Silvestri JM, Corwin M, Smok-Pearsall S, et al.: Ability to predict a family's use of a home respiratory inductance plethysmography (RIP) monitor. The American Pediatric Society and the Society for Pediatric Research annual meeting. New Orleans, LA. Pediatric Research 43(4 pt 2): 119A, 1998.

Weese-Mayer D, Corwin M, DiFiore J, et al.: Accuracy of the respiratory inductance plethysmography Collaborative Home Infant Monitoring Evaluation (CHIME) monitor in identifying obstructed breaths. The American Pediatric Society and the Society of Pediatric Research annual meeting. New Orleans, LA. Pediatric Research 43(4 pt 2): 90A, 1998.

Hunt CE, Corwin MJ, Lister G, Weese-Mayer DE, Neuman MR, Tinsley L, Baird TM, Keens TG, Cabral HJ. Longitudinal assessment of hemoglobin oxygen saturation in healthy infants during the first 6 months of age. Collaborative Home Infant Monitoring Evaluation (CHIME) Study Group. J Pediatr. 1999 Nov;135(5):580-6.

Silvestri JM, Hufford DR Jr, Durham J, Pearsall SM, Oess MA, Weese-Mayer DE, Hunt CE, Levenson SM, Corwin MJ. Assessment of compliance with home cardiorespiratory monitoring in infants at risk of sudden infant death syndrome. Collaborative Home Infant Monitoring Evaluation (CHIME). J Pediatr. 1995 Sep;127(3):384-8.

Hunt CE. Sudden infant death syndrome and subsequent siblings. CHIME Steering Committee. Collaborative Home Infants Monitoring Evaluation. Pediatrics. 1995 Mar;95(3):430-2. No abstract available.

Brooks LJ, DiFiore JM, Martin RJ. Assessment of tidal volume over time in preterm infants using respiratory inductance plethysmography, The CHIME Study Group. Collaborative Home Infant Monitoring Evaluation. Pediatr Pulmonol. 1997 Jun;23(6):429-33.

Crowell DH, Brooks LJ, Colton T, Corwin MJ, Hoppenbrouwers TT, Hunt CE, Kapuniai LE, Lister G, Neuman MR, Peucker M, Ward SL, Weese-Mayer DE, Willinger M. Infant polysomnography: reliability. Collaborative Home Infant Monitoring Evaluation (CHIME) Steering Committee. Sleep. 1997 Jul;20(7):553-60.

Corwin MJ, Lister G, Silvestri JM, Peucker M, Brooks LJ, Ward SL, Hunt CE, Neuman MR, Crowell DH, Colton T. Agreement among raters in assessment of physiologic waveforms recorded by a cardiorespiratory monitor for home use. Collaborative Home Infant Monitoring Evaluation (CHIME) Study Group. Pediatr Res. 1998 Nov;44(5):682-90.

Study ID Numbers:  199/12190; YALESM-CHIME-HD9102
Record last reviewed:  January 2000
Last Updated:  October 13, 2004
Record first received:  October 18, 1999
ClinicalTrials.gov Identifier:  NCT00004392
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-04-08


Source: ClinicalTrials.gov
Cache Date: April 9, 2005


Take control over your directory listings...INSTANTLY

Every day, thousands of users find businesses like yours in the GoldBamboo directory.

Limited Time Offer!!!

For only $50 a year, a savings of 50% off our standard rate:

  • Edit your listing (whenever you want!)
  • Link to your website
  • Choose which categories you are listed in
  • Describe your services

The process will take only a few minutes and consists of 3 easy steps:

1. Register     >     2. Edit Listings     >     3. Publish

Your Company
your street
yourtown, YS 12345
888-888-8888



No Thanks

Popular Treatments

Acne Treatment ADHD Treatment Allergy Treatment Alzheimer's Treatment
Anemia Treatment Arthritis Treatment Asthma Treatment Bipolar Disorder Treatment
Bird Flu Treatment Bladder Cancer Treatment Bladder Control Treatment Blood Pressure Treatment
Brain Tumor Treatment Breast Cancer Treatment Bronchitis Treatment Cancer Treatment
Cancer Alternative Treatment Cataract Treatment Cirrhosis Treatment Colitis Treatment
Colon Cancer Treatment Common Cold Treatment Conjunctivitis Treatment Constipation Treatment
Crohn's Disease Treatment Cystic Fibrosis Treatment Depression Treatment Dermatitis Treatment
Diabetes Treatment Edema Treatment Epilepsy Treatment Erectile Dysfunction Treatment
Fibromyalgia Treatment GERD Treatment Glaucoma Treatment Gout Treatment
Hay Fever Treatment Headache Treatment Heart Disease Treatment Hepatitis Treatment
High Blood Pressure Treatment High Cholesterol Treatment Hives Treatment Hypertension Treatment
Hypoglycemia Treatment IBS Treatment Impotence Treatment Indigestion Treatment
Infertility Treatment Influenza Treatment Insomnia Treatment Lactose Intolerance Treatment
Leukemia Treatment Lung Cancer Treatment Lyme Disease Treatment Macular Degeneration Treatment
Menopause Treatment Migraine Treatment Osteoarthritis Treatment Osteoporosis Treatment
Pancreatic Cancer Treatment PMS Treatment Pneumonia Treatment Prostate Diseases Treatment
Restless Leg Treatment Rheumatoid Arthritis Treatment Sepsis Treatment Sinusitis Treatment
Skin Cancer Treatment Sleep Apnea Treatment Snoring Treatment Stroke Treatment
Testicular Cancer Treatment
GoldBambooTM

Your Integrative Health and Wellness Resource for Vaccines and Sudden Infant Death Syndrome.

October 11, 2008



Page Updated: June 12, 2007
Disclaimer: All material displayed on the GoldBamboo.com website is provided for educational purposes only. Consult a physician regarding the applicability of any information found on GoldBamboo.com to your symptoms or medical condition.

Massachusetts Law | Home | About Us | Link To Us | Feedback | Disclaimer | Privacy Policy | Terms of Use | Google Co-op | Health Forums

Copyright © 2004-2008 - Gold Bamboo LLC
All rights reserved.

HONcode accreditation seal.

We comply with the HONcode standard for health trust worthy information:
verify here.